Invention Grant
- Patent Title: Effector-deficient anti-CD32A antibodies
- Patent Title (中): 效应性缺陷型抗CD32A抗体
-
Application No.: US14555556Application Date: 2014-11-26
-
Publication No.: US09382321B2Publication Date: 2016-07-05
- Inventor: John Francis , Ali Amirkhosravi , Todd Meyer , Liza Robles-Carrillo
- Applicant: Adventist Health System/Sunbelt Inc.
- Applicant Address: US FL Altamonte Springs
- Assignee: Adventis Health System/Sunbelt, Inc.
- Current Assignee: Adventis Health System/Sunbelt, Inc.
- Current Assignee Address: US FL Altamonte Springs
- Agency: McNeill Baur PLLC
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28
Abstract:
Effector-deficient anti-CD32a monoclonal antibodies are encompassed, as are method and uses for treating CD32a-mediated diseases and disorders, including, thrombocytopenia, allergy, hemostatic disorders, immune, inflammatory, and autoimmune disorders.
Public/Granted literature
- US20160145336A1 EFFECTOR-DEFICIENT ANTI-CD32A ANTIBODIES Public/Granted day:2016-05-26
Information query
